Combined genetic polymorphism and risk for development of lung cancer
- 1 November 1997
- journal article
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 381 (2) , 189-200
- https://doi.org/10.1016/s0027-5107(97)00166-8
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Polymorphism of metabolizing genes and lung cancer histology: prevalence of CYP2E1 in adenocarcinomaCancer Letters, 1997
- Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patientsCarcinogenesis: Integrative Cancer Research, 1996
- Genetic Polymorphism of Cytochromes P450 1A1, 2D6 and 2E1: Regulation and Toxicological SignificanceJournal of Occupational and Environmental Medicine, 1995
- PCR-based CYP2D6 genotyping for Finnish lung cancer patientsPharmacogenetics, 1993
- Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6Pharmacogenetics, 1993
- Glutathione S-Transferase and Epoxide Hydrolase Activity in Human Leukocytes in Relation to Risk of Lung Cancer and Other Smoking-Related CancersJNCI Journal of the National Cancer Institute, 1992
- Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypesPharmacogenetics, 1991
- cDNA-expressed human cytochrome P450s: a new age of molecular toxicology and human risk assessmentMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991
- Identification of the primary gene defect at the cytochrome P450 CYP2D locusNature, 1990
- Evidence for Mendelian Inheritance in the Pathogenesis of Lung CancerJNCI Journal of the National Cancer Institute, 1990